glial progenitor cell-based treatment modeling neurological disease 
diseases myelin among prevalent disabling conditions neurology diseases include vascular inflammatory demyelinating disorders adulthood well childhood leukodystrophies cerebral palsy fundamentally glial disorders may amenable treatment glial progenitor cells gpcs give rise astroglia myelin-producing oligodendrocytes given development new methods generating isolating human gpcs myelin disorders may now compelling targets cell-based therapy addition efficient engraftment expansion human gpcs murine hosts led development human glial chimeric mouse brains provides new opportunities studying species-specific roles human glia cognition well disease pathogenesis 
